Get started
Author

Stefanie Lerch

Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial
2024 · Jürgen Beck, Christian Fung, et al. · The Lancet · 125
Continuous Sunitinib Treatment in Patients with Advanced Hepatocellular Carcinoma: A Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) Multicenter Phase II Trial (SAKK 77/06)
2010 · Dieter Koeberle, Michael Montemurro, et al. · The Oncologist · 92
PDF
SWIFT DIRECT: Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke: Methodology of a randomized, controlled, multicentre study
2021 · Urs Fischer, Johannes Kaesmacher, et al. · International Journal of Stroke · 46
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
2007 · G. D'Addario, D. Rauch, et al. · Annals of Oncology · 43
PDF
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
2010 · C. Rochlitz, T. Ruhstaller, et al. · Annals of Oncology · 26
PDF
Cerebral formation in situ of S-carboxymethylcysteine after ifosfamide administration to mice: A further clue to the mechanism of ifosfamide encephalopathy
2005 · Stefanie Lerch, Adrian Küpfer, et al. · Toxicology Letters · 15
Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial
2024 · Urs Fischer, Christian Fung, et al. · European Stroke Journal · 12
PDF
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial)
2025 · Stefan Halbherr, Stefanie Lerch, et al. · PLoS Medicine · 8
PDF
Bevacizumab and pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer: A multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)
2009 · C. Rochlitz, C. Spirig, et al. · Journal of Clinical Oncology · 2
5019 Pegylated liposomal doxorubicin and Bevacizumab as first-line therapy for locallyrecurrent or metastatic breast cancer – a multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)
2009 · C. Rochlitz, R. von Moos, et al. · European Journal of Cancer Supplements · 1
Studies into the mechanism of ifosfamide-induced encephalopathy
2004 · Lerch, Stefanie · edoc (University of Basel) · 1
PDF
Preliminary results of a randomised study using WR-2721 in radiation therapy alone in patients with head and neck cancer
1997 · V. Strnad, R. Sauer, et al. · European Journal of Cancer · 1
Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial
2024 · Urs Fischer, Christian Fung, et al. · Newcastle University ePrints (Newcastle Univesity)
Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial
2024 · Jürgen Beck, Christian Fung, et al. · Newcastle University ePrints (Newcastle Univesity)
Wissenschaft_Macht_Nachwuchs. Zur Situation von Nachwuchwissenschafter_innen.
2016 · Susanne Kink, Stefanie Lerch · Feministische Studien
Wissen ist Macht. Ist Wissen Macht?
2014 · Stefanie Lerch · transcript Verlag eBooks
Should phase II cancer screening trials include a control arm? 30th Annual Conference of the International Society for Clinical Biostatistics, August 23-27, 2009, Prague
2009 · Jan C. Schuller, Peter Brauchli, et al. · Bern Open Repository and Information System (University of Bern)
Quality of life (QoL) in SAKK 19/03: A multicenter phase II study of first-line gefitinib followed by chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Swiss Group for Clinical Cancer Research (SAKK)
2006 · G. D’Addario, F. Strasser, et al. · Journal of Clinical Oncology
Works count: 27
Citation count: 372
H-index: 8
I10-index: 7
Year
Topic
Type